(Q35010248)

5 August 2017

title

Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma (English)

1 reference

5 August 2017

1 reference

Xiao-Yu Yin

1

1 reference

5 August 2017

Ming-De Lü

2

1 reference

5 August 2017

Li-Jian Liang

3

1 reference

5 August 2017

Jia-Ming Lai

4

1 reference

5 August 2017

Dong-Ming Li

5

1 reference

5 August 2017

Ming Kuang

6

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

World Journal of Gastroenterology

5 August 2017

published in

1 reference

5 August 2017

volume

11

1 reference

5 August 2017

issue

16

1 reference

5 August 2017

page(s)

2526-2529

1 reference

Combined 5-fluorouracil/systemic interferon-beta gene therapy results in long-term survival in mice with established colorectal liver metastases

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

In vivo assessment of the antiproliferative properties of interferon-alpha during immunotherapy: Ki-67 (MIB-1) in patients with metastatic renal cell carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

8 July 2018

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

The interferon in TLR signaling: more than just antiviral

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Combinations of anticancer drugs and immunotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

5-Fluorouracil: mechanisms of action and clinical strategies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Metastatic renal carcinoma comprehensive prognostic system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Systemic treatment of hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Adjuvant interferon-alpha in malignant melanoma: current status

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.

8 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I16.2526

Hepatic radiofrequency ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I16.2526

Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I16.2526

Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I16.2526

Treatment of acute lymphoblastic leukemia in the elderly: an evaluation of interferon alpha given as a single agent after complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I16.2526

Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305648

Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation

26 October 2018

1 reference

12 December 2020

Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center

1 reference

12 December 2020

Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years

1 reference

12 December 2020

Management of hepatocellular carcinoma

1 reference

12 December 2020

Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I16.2526

1 reference

5 August 2017

1 reference

5 August 2017

1 reference